等待開盤 09-18 09:30:00 美东时间
+0.670
+7.60%
JP Morgan analyst Matthew Boss maintains LuxExperience (NYSE:LUXE) with a Neutral and raises the price target from $9 to $10.
09-17 22:20
U.S. stocks were mixed, with the Nasdaq Composite gaining around 150 points on Wednesday. Shares of LuxExperience BV-ADR (NYSE:LUXE) rose sharply after the company reported fourth-quarter results. LuxExperience reported quarterly losses of 21 cents per share which missed the analyst consensus estima...
09-16 21:57
LuxExperience (NYSE:LUXE) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 50 percent. This is a 19.23 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $771.703 million wh...
09-16 18:03
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects LuxExperience BV-ADR (NYSE:LUXE) to report a quarterly loss of 14 cents per share on revenue of $727.39 million before the opening bell, accordi...
09-16 14:52
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Wednesday. Shares of ServiceTitan Inc (NASDAQ:TTAN) fell sharply in pre-market trading after the company reported second-quarter financial results and issued third-quarter sales guidance with its midpoint below e...
09-09 20:02
Shares of Mission Produce Inc (NASDAQ:AVO) rose sharply in pre-market trading after the company posted better-than-expected third-quarter results. Mission Produce reported quarterly earnings of 18 cents per share, which beat the analyst consensus estimate of 12 cents per share. The company reported ...
09-09 16:39
今日重点评级关注:Ascendiant Capital:维持Alzamend Neuro"买入"评级,目标价从25美元升至26美元;Tigress Financial:维持Legence"买入"评级,目标价从125美元升至130美元
08-20 08:39
TD Cowen analyst Oliver Chen maintains LuxExperience (NYSE:LUXE) with a Buy and raises the price target from $8 to $9.
08-19 22:24
今日重点评级关注:Oppenheimer:维持Protara Therapeutics"跑赢大市"评级,目标价从25美元升至28美元;Piper Sandler:维持Bright Minds Biosciences"超配"评级,目标价从190美元升至220美元
05-21 12:05
TD Cowen analyst Oliver Chen maintains LuxExperience (NYSE:LUXE) with a Buy and lowers the price target from $12 to $8.
05-21 00:36